NCT03340896 Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03338790 An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT03337698 A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer) Status TERMINATED Phase PHASE1/PHASE2
NCT03330106 A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03329378 Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer Status TERMINATED Phase PHASE2
NCT03328364 A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden Status COMPLETED Phase N/A
NCT03317158 Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder Status RECRUITING Phase PHASE1/PHASE2
NCT03311555 A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR) Status COMPLETED Phase PHASE2
NCT03288870 Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS) Status UNKNOWN Phase PHASE2/PHASE3
NCT03269162 Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection Status UNKNOWN Phase PHASE3
NCT03264547 A Study to Compare Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + Trastuzumab Status COMPLETED Phase PHASE3
NCT03230734 Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03228186 Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT03221426 Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) Status COMPLETED Phase PHASE3
NCT03218826 PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery Status COMPLETED Phase PHASE1
NCT03211117 Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer Status COMPLETED Phase PHASE2
NCT03209206 The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence Status UNKNOWN Phase PHASE2
NCT03199885 Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT03178552 A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT03177174 Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma Status COMPLETED Phase NA